Introduction
Thyroid cancer has in general terms a good prognosis, as the majority of the patients with this disease can be cured with surgery and radioactive iodide treatment.
The ability of differentiated thyroid cells to accumulate iodide is clinically highly relevant because it makes it possible for patients with thyroid cancer to be treated with ablative doses of radioactive iodide after an adequate stimulation by thyroid-stimulating hormone (TSH) (1) . However, some patients develop metastatic disease refractory to radioactive iodide treatment and their life expectancy significantly decreases. Thus, the maintenance of the thyroid differentiated phenotype during tumor transformation has a critical impact in thyroid cancer patient's survival (2) .
The maintenance of the thyroid differentiated phenotype requires the presence of PAX8, a member of the paired box (PAX) family of transcription factors (3) . Together with the other thyroid transcription factors NKX2-1 and FOXE1, PAX8 is involved in thyroid follicular cell development and expression of thyroid-specific genes such as the sodium/iodide symporter (SLC5A5, also named as NIS), thyroglobulin (Tg) and thyroperoxidase (TPO) (4) (5). These genes are essential for thyroid differentiation as they mediate the metabolism of iodide leading to the synthesis of active thyroid hormone. One of the most important and well established transcriptional targets of PAX8 is NIS. This symporter is a key plasma membrane protein that mediates active iodide transport in the thyroid and other tissues (6) . In the healthy thyroid, NISmediated iodide uptake is the first step in thyroid hormone biosynthesis. NIS also plays a central role in thyroid cancer treatment. As long as a few NIS molecules are functionally expressed in thyroid cancer cells, thyroid cancer is successfully treated by thyroidectomy followed by radioactive iodide ( 131 I) administration. Radioactive iodide selectively targets and destroys any remnant or metastatic NIS-expressing thyroid cancer cells. Radioactive iodide treatment is the most effective targeted internal radiation anticancer therapy ever devised and it has been in use for over 60 years.
Therefore, loss of the thyroid differentiated phenotype, particularly loss of NIS function, is one of the most important hallmarks of thyroid cancer progression, leading to iodide-refractory metastatic disease and a worse outcome of the patients (7, 8) .
MiRs inhibit translation or induce mRNA degradation in general by binding to the 3`untranslational region (3'UTR) of target mRNAs. Since initial observation, about 3000 human miRs have been registered in miRBase (v.20.0) (9) and are thought to regulate 50% of the transcriptome. Although a previous classical approach of cloning has partially revealed miR expression profile in thyroid tumors (10, 11) low throughput with low sensitivity and poor resolution makes these approaches limited to define miRNome. Genome-wide sequencing of miRs can identify miRNome in-depth, which reveals miR expression differences as well as the individual miR abundance. As a minimum threshold amount must be reached for miRs to repress target mRNAs (12) (13) (14) (15) , the abundance of miRs and their ratios in the entire miRNome of specific cell or tissue may be very important for their functions.
When preparing this manuscript, results from The Cancer Genome Atlas (TCGA) project based on a comprehensive multiplatform analysis of 496 papillary thyroid carcinomas (PTCs), the most common type of thyroid cancer, were published (16) . In such work several miRs were associated with less differentiated tumors. Here, we took an integrated approach and based on the abundance of the miRs and their ratios in the entire miRNome, we analyzed miRs and the transcriptome from paired normal and tumor thyroid tissue from eight patients with PTC. Our aim was to uncover the underlying miR regulatory network that determines differentiation in PTCs and to provide functional studies to characterize those miRs involved in the modulation of genes essential for thyroid differentiation and iodide uptake, namely PAX8 and NIS.
Materials and Methods
Thyroid tissue samples. For the sequencing experiment, fresh frozen samples from PTC tumors (n=8) and contralateral normal thyroid tissue from the same patient (n=8) were collected at the Biobank of the Hospital Universitario La Paz (Madrid, Spain). The clinical characteristics of patients are summarized in Table S1 and other details in Supplementary Material and Methods. An independent cohort of sixteen samples from PTC tumors was used for validation.
Next-Generation Sequencing. The sequencing procedure was carried out using the Genome Analyzer IIx Platform (Illumina®) at the Genomics Core Unit of CNIO (the Spanish National Cancer Research Centre, Madrid, Spain) using the standard protocols recommended for small RNA-seq (Illumina® TruSeq® Small RNA) and mRNA-seq (Illumina® TruSeq® Stranded mRNA). Using Cutadapt software (v. 1.2.1), 3' adapters from Small RNA reads were removed, filtering reads with lengths of 17-34 nt. The remaining short reads were aligned to the human genome (UCSC, hg19 assembly) using Bowtie algorithm (v0.12.7)(17) with the criteria of perfect match. Reads mapping on each mature miR genomic location were counted using HTSeq-count (v. 0.5.4), toward the miR annotation from miRBase version 20 (hg19 assembly, June 2013). Clean sequenced reads (excluding reads containing ambiguous base and adaptor contaminants)
were used for further analysis and reads classified as small RNAs from other species (rRNA, tRNA, scRNA, snRNA, snoRNA, repeat-associated small RNAs and mRNAs (exons/introns) were excluded (Fig. S1 ). The mRNA reads were aligned to the human genome (UCSC, hg19 assembly) using TopHat v.2.0.4 (18), permitting 2 mismatches and a maximum of 5 multi-hits. The Gene-level expression was calculated as the sum of all read counts over their exons by using Htseq-count and the gene annotation from the reference genome (hg19, UCSC) (19) . All sequencing data can be downloaded from Gene Expression Omnibus (GEO) under accession number GSE63511.
Bioinformatic Predictions of Target Genes. TargetScan algorithm (20) medium supplemented with a six-hormone mixture (1nM TSH, 10μg/ml insulin, 10ng/ml somatostatin, 5μg/ml transferrin, 10nM hydrocortisone and 20ng/ml glycyl-Lhistidyl-L-lysine acetate) all from Sigma-Aldrich, and 5% donor calf serum (Life Technologies). Near-confluent cells were starved for TSH and insulin in the presence of 0.2% serum (starvation medium) for 4 d. Then, TSH (0.5mU/mL) alone or together with IGF1 (100 ng/mL) or TGFβ (10 ng/mL) (the last two from PeproTech) were added to the culture medium at 24h and RNA was then extracted. Pax8 silencing was performed either transfecting the cells with Pax8 siRNA or Scrambled conditions (10ng siRNA /ml) (Dharmacon) as described previously (22) or transducing the cells with lentivirus containing short hairpin RNA against Pax8, using a shScramble as control (pGIPZ_Pax8 (clon#V3LHS_408573) and pGIPZ-Scramble respectively (Open Biosystem). VSV-G pseudotyped lentivirus production was The results in qRT-PCR, luciferase activity and iodide uptake are expressed as the mean ± SEM of at least three different experiments performed in triplicate. Statistical significance was determined by t test analysis (two tailed), and differences were considered significant at a P value of <0.05. thyroid express a large, highly similar set of abundantly expressed miRs that corresponds to the functional miRNome of the thyroid.
Results

Identification of miRNomes in normal thyroid
We next wanted to know which miRs are the major players in PTC pathogenesis. As only a few miRs are abundantly expressed in the miRNome and they seem to be the most important in thyroid biology, only miRs with CPM >1000 and more than 1.5-fold change were considered most likely to be important in PTC pathogenesis in this study. We identified a set of 12 upregulated and 8 downregulated miRs after pair-wise comparison between the 8 malignant tumors and their corresponding normal samples (Table 1 ). In the list of upregulated miRs the most abundant and upregulated by far was miR-146b-5p. Interestingly, miR-146b-3p, formerly thought to be a passenger strand, was also among the most abundant upregulated miRs. Because miR-155 and miR-34a are close to the threshold of 1000 CPMs and have been previously shown to be deregulated in PTC, we decided to consider them as more likely to be functional. On the other hand, as miR-21-3p and miR-181a-2-3p are not included in TargetScan database, they were not considered in this work. In the list of downregulated miRs the three most abundant were miR-451a, miR-486 and miR100b. Low abundant miRs being significantly deregulated in PTC are shown in Supplementary dataset 2 and, although its biological relevance remains to be proved, we cannot rule out that they play a functional role. Subsequent validation through qRT-PCR of several deregulated miRs was performed in an independent cohort of sixteen patients with PTC. (Fig. S2A) . We also performed next-generation sequencing in eight extra tumors with PTC obtaining similar results (Fig. S2B) . Together, the miRNomes of human normal thyroid and PTC led us to identify the consistently deregulated miR in thyroid cancer.
Identification of a miR regulatory network in PTC reveals miRs that regulate genes essential for thyroid differentiation. To identify target genes of the most abundant deregulated miRs, we firstly performed next-generation sequencing of mRNA in the paired normal and tumor thyroid tissue from the same eight patients with PTC.
Overall, 910 genes were significantly deregulated (536 were overexpressed and 374 were downregulated) (Supplementary dataset 3) . We further characterized the biological signatures associated with our sequencing analysis. Overrepresentation analysis (ORA) based on the KEGG pathways database revealed enrichment of cell membrane-mediated pathways (Table S2) , including ECM-receptor interaction, cell adhesion molecules (CAMs) and focal adhesion. This finding highlights the role of integrins among other membrane-bound mediators in thyroid malignancy, similar to what has been previously described (29) . ORA also revealed enrichment of Small cell lung cancer and TGFβ signaling pathways, highlighting the role of these canonical pathways in thyroid cancer. shows that some genes essential for thyroid differentiation are under the influence of this network (Fig 1A, circles in red) . The three miRs predicted to regulate the largest number of targets are miR-182, miR-146b-3p and miR-34a (regulating 71, 66 and 65 targets, respectively; Fig.1B) Network analysis have shown that genes that are subject to extensive miRs regulation, referred as to target hubs, are more likely to be biologically relevant (30, 31) .
In addition, it has been shown that many transcription factors (TFs) are among these target hubs and there is increasing evidence of reciprocal regulation between miRs and TFs as well as the existence of extensive coordination in the regulation of shared targets genes at the genome-scale level (32, 33) . Considering only bioinformatics prediction, we found that 48 out of 217 (22%) of the target genes in PTC were predicted to be regulated by 5 or more miRs and were thus considered target hubs (Fig.1A , circles with a thick edge in the center of the netwok and Fig.1C) . Similar results were obtained using a second algorithm, DIANAmicroT (Fig.S3) . Among these genes, several important tumor suppressors and transcription factors involved in human cancer were found (Table S3) . Of note, PAX8 is predicted to be modulated by five miRs revealing this nuclear protein as a target hub.
As miR-146b-5p and -3p are two of the most abundant upregulated miR in PTC, we focused our analysis on both strands generated by the same pre-miR. We found that miR-146b-5p and miR-146b-3p target 54 and 66 genes respectively, being 22 of these genes targeted by both strands ( Fig. 2A and B) . The majority of these target genes are related to ECM-receptor interaction, cell adhesion molecules (CAMs) and focal adhesion ( Fig. 2C and Table S4 ). Of note, miR-146b-3p targets two genes essential for thyroid differentiation, namely PAX8 and SLC5A5 (NIS) (Fig. 2B, circles in red) . In addition, miR-146b-5p targets DIO2, the iodothyronine deiodinase that converts T4 into 
T3; and both miR-146b-3p and -5p target IYD (DEHAL1), the iodotyrosine deiodinase that controls the recycling of iodide for thyroid hormone synthesis (Fig. 2B, circles in   red) . Overall, these results uncover the target genes of miR-146b-5p and -3p in PTC, revealing that this miR precursor is a key regulator of iodide-metabolizing genes.
Interestingly, SLC5A5 (NIS), IYD (DEHAL1) and DIO2 are downstream targets of PAX8 (22, 34) . Therefore, miR-146b regulates both the transcription factor (PAX8) and its downstream target genes (NIS, DEHAL1 and DIO2), suggesting that miR-146b forms a feedforward loop that controls gene expression through a direct and indirect mechanism (Fig. 2 D) .
We wanted to extend our analysis to other miRs involved in thyroid differentiation. According to TargetScan, we found that a group of eleven upregulated miRs were predicted to target genes essential for thyroid differentiation (Table S5) . As mentioned before, PAX8 is predicted to be modulated by five miRs (miR-146b-3p, miR-182, miR-221, miR-222, and let-7e). However, downregulated miRs are also targeting PAX8, which might be counteracting the inhibitory effects mediated by the upregulated miRs. NIS is predicted to be modulated by miR-146b-3p and by miR-21-5p. FOXE1 is predicted to be modulated by miR-155 and TSHR by miR-34a, though other downregulated miRs are involved. TG seems not to be modulated by any deregulated miRs in PTC. 
particular organism or tissue. As mentioned before, we observed that miR-146b-3p was predicted to regulate both the transcription factor (PAX8) and its downstream target gene (NIS). We therefore wanted to explore if miR-146b and PAX8 shared more target genes in the sequencing data derived from the tumor samples. For this purpose we used our previously characterization of the downstream targets genes of PAX8 in the rat thyroid cell line PCCl3 (22) . We firstly confirmed that PAX8 was significantly downexpressed in the tumours (FC 0.5 p<0.05) (not shown). We next searched in our sequence analysis and found that 51 downregulated genes in the tumors were downstream target genes of PAX8. Interestingly, PAX8 and miR-146b-3p shared 15 target genes including SLC5A5 (NIS) and IYD (DEHAL) (Fig. 3A and B) .
We next wanted to study if PAX8 and miR-146b were regulating each other. To explore if PAX8 regulates miR-146b expression, we first searched for putative binding sites of PAX8 in the miR-146b regulatory region. We found several PAX8 binding elements upstream the transcription start site of both rat and human miR-146b ( Fig.4A and Supplementary dataset 4). We next studied the effect of Pax8 silencing on miR146b expression after siRNA transfection in PCCl3 cells (Fig. 4B) . We observed that the levels of miR-146b significantly decreased after silencing Pax8, suggesting that this TF positively regulates the transcription of miR-146b. The same results were obtained when Pax8 was silenced by shRNA (not shown) Conversely, to explore if miR-146b regulates PAX8 expression, NthyOri cells were transfected with an expression vector encoding for the miR-146b precursor, which expresses the two strands miR-146b-5p and miR-146-3p. Overexpression of miR-146b decreased the protein levels of endogenous PAX8 (Fig. 4C ) yet no significant effect was observed in the mRNA levels (Fig. 4D) . TargetScan-based bioinformatics predictions showed that there were three putative binding sites in the 3'UTR of PAX8 for miR- (Fig. 4E) . Moreover, we addressed if miR-146b-3p was specifically targeting the 3'UTR of PAX8. We thus generated a luciferase reporter vector encoding for the entire 3'UTR and another one for the 3'UTR reverse, used as a negative control. Using HeLa cells, we observed that miR-146b overexpression induced a 30% decrease of the luciferase activity on average of the entire 3'UTR of PAX8 (Fig. 4F) . These results show that miR-146b-3p directly represses PAX8 expression by targeting the 3'UTR.
146b-3p
And overall, we provide evidence whereby in thyroid cells operate a negative feedback loop in which the transcription factor (PAX8) limits its own activity by inducing a repressor (miR-146b) (Fig. 4G ).
MiR-146b-3p decreases NIS expression by targeting the 3'UTR and is regulated by
TSH. To explore whether miR-146b-3p was able to downregulate NIS expression, we firstly used MDCKhNIS. This cell system expresses NIS in the cell membrane and mediates active transport of iodide into the cytoplasm (24) . We transfected these cells an expression vector encoding for the miR-146b precursor. We observed that miR-146b decreases protein levels of NIS (Fig. 5A ), yet no significant effect was observed in the mRNA levels (Fig. 5B) . Additionally, an 80% reduction in iodide uptake was seen ( Fig   5C) . These results show that miR-146b impairs NIS mRNA translation and subsequently decreases protein levels and transport activity of NIS.
We next wanted to address if miR-146b-3p was specifically targeting the 3'UTR of hNIS. The bioinformatics predictions informed us that one putative target site was present at positions 3-9 in the 3'UTR (Fig. 5D ). We generated a luciferase reporter vector encoding for the entire 3'UTR and another one encoding for a short region of 7nt in tandem harboring the target site at positions 3-9 (called 3-9nt segm). The reverse constructs of the entire 3'UTR and the 3-9nt segm were used as negative controls. After average both with the entire 3'UTR and the 3-9nt segm when we transfected cells with miR-146b (Fig. 5E) . These results provide evidence that the direct repression of NIS expression by miR-146b-3p requires a binding site at positions 3-9 of the 3'UTR.
We finally wanted to investigate if miR-146b was hormonally regulated in differentiated thyroid cells. TSH is essential for the thyroid cell to express the genes involved in the uptake and metabolism of iodide and hence, allows the thyroid cell to be fully differentiated. Thus, we assumed that those miRs more likely to be involved in targeting thyroid differentiating genes are necessarily downregulated by TSH in normal thyroid cells. To explore if the expression of miR-146b was dependent on TSH regulation we used rat PCCl3 cells. MiR-146b was strongly downregulated after stimulating the cells with TSH (Fig. 5F ). In addition, this downregulation was recovered by IGF-1 and TGFβ, known repressors of TSH-induced NIS expression (35, 36) (Fig.   5G ). Thus, endogenous levels of miR-146b are tightly controlled by TSH in differentiated thyroid cells.
Discussion
In this work we identified a master miR regulatory network in PTC that is involved in essential biological processes such as differentiation. Functional studies characterized miR-146b-3p as a repressor of PAX8 and NIS and showed that miR-146b and PAX8 regulate each other, unveiling a regulatory circuit that determines the differentiated phenotype in PTC. time that NIS is postranscriptionally modulated by miRs in thyroid cancer. Very recently, it has been shown that miR-339 modulates NIS expression in rat normal thyroid cells (37) , yet this miR has not been shown to be deregulated in thyroid cancer in previous studies including ours (16, 38, 39) . We consistently show that miR-146b-3p binds to the 3`UTR of NIS (site 3-9 nt) leading to an impaired translation of the protein and subsequently decreasing the iodide uptake of the cells. Several mechanisms have been proposed to explain NIS repression in thyroid cancer in order to establish new therapeutic approaches to try to reinduce iodide uptake (8, 40) . All of them are based on the transcriptional repression induced by aberrant signaling pathways and/or epigenetic events. Here we show an additional mechanism based on the postrancriptional regulation of NIS mediated by miRs.
We also show that miR-146b-3p is strongly downregulated by TSH in normal thyroid cells (PCCl3) and its expression is recovered by IGF1 and TGFβ, two known repressors of NIS expression via PI3K and Smads respectively (35, 36) . This highlights the importance of a tight hormonal regulation of miR expression in the thyroid cell. In accordance, it has been previously demonstrated that TSH signaling through CREB1 represses several miRs by physically interacting with their regulatory region (41) . As TSH signaling is impaired during thyroid carcinogenesis, the miRs are able to escape from this TSH-mediated repression. In addition to the impairment of TSH signaling, TGFβ and PI3K signaling are known to be hyperactivated in thyroid cancer (8, 42) .
Thus, we suggest that aberrant signaling of key growth factors and cytokines (i.e. TSH, TGFβ and IGF1) are contributing to the strong upregulation of miR-146b seen in thyroid cancer (upto 35 fold). 
Apart from regulating NIS, the most abundant miRs are involved in the modulation of other genes essential for thyroid differentiation. PAX8 is a transcription factor that specifically governs the transcription of NIS and is necessary for the development of the thyroid gland and for maintaining the differentiated state in the thyroid of the adult. Moreover, this TF is a master regulator of other key cellular processes such as cell cycle regulation, DNA repair, replication, metabolism and cell polarity (22, 43) . We show that PAX8 is predicted to be targeted by five of the most abundant upregulated miRs in thyroid cancer (Fig.1C and Table S3 ) suggesting that this TF is a target hub which is in accordance with its biological importance in the thyroid gland. One of such miRs, miR-146b-3p, effectively represses PAX8 through binding to its 3'UTR. Intriguingly, we further show that PAX8 and miR-146b regulate each other and share common targets, including iodide metabolizing genes. This provides evidence that such miR-TF pair forms small regulatory circuits that constitutes a successful mechanism of regulating gene expression in the thyroid.
Regulatory circuits involving miRs and TFs are prevalent mechanisms of gene expression at the genome scale-level (44, 45) . One of such regulatory circuits is the feed-forward loop where the miR simultaneously represses the TF and its target genes. This circuit functions to suppress leaky transcription and hence target genes will only be expressed if the levels of the miR decrease. Here we describe a miR146b/PAX8/NIS circuit as an example of a feed-forward loop (Fig.2D and Fig. 6 ) in which the miR (146b) represses the TF (PAX8) and its downstream target (NIS) (Fig.   2D ). In addition and complementary to this feed-forward loop, we also describe another regulatory circuit in which miR-146b and PAX8 form a negative feedback loop where the TF (PAX8) limits its own activity by inducing a repressor (miR-146b) (Fig. 4G) .
Such a loop can result in coexpression of both components, either in steady-state levels or in oscillation. (46) . The expression of both components depends on additional input signals. As a consequence, network circuits allow the spreading of regulatory effects.
An upstream signal activates the miR, which in turns represses all its direct targets including the TF. As a result, all downstream targets of the TF are also repressed. In thyroid cells the spreading of regulatory effects concerning PAX8 and miR-146b affect key biological functions such as thyroid differentiation. Particularly, common target genes such as SLC5A5 (NIS), IYD (DEHAL) and DIO2 reveal the importance of controlling the expression of a set of genes regulating the metabolism of iodide.
Taken together, we propose an integrated model that may be operating to determine the thyroid differentiated phenotype and in the end, the uptake of iodide (Fig   6) . Thyroid cells are under the control of TSH and show lower levels of miR-146b and higher levels of PAX8. Upon an oncogenic signal (e.g. BRAF), TSH signaling is impaired and TGFβ and PI3K signaling hiperactivated leading to higher levels of miR146b and lower levels of PAX8. As a result, tumor cells adopt a less differentiated state that, for instance, makes them more insensitive to radioactive iodide. However, this state can change if an external signal transiently overcomes the oncogenic signal by decreasing the levels of the miR-146b. An example of such an external signal can be exogenous administration of recombinant human TSH, which is widely used in the clinical practice to enhance iodide uptake in thyroid cancer patients. Another example of an external signal that may promote a change in the differentiated state is kinase inhibitors (i.e. selumetinib).
We also unveiled for the first time the main target genes of miR-146b-5p and 146b-3p in PTC, both of them strands generated by the miR-146b precursor. As previously shown by other studies (39, 47) threshold amount to be considered as functional. MiR-146b has been demonstrated to be a prognostic factor for PTC as it is associated with aggressive clinicopathological features and a poor clinical outcome (48) . It has also been proven to be elevated in the serum of patients with PTC (49). Some of its target genes have been validated in thyroid cancer (50) . Thus, although more functional studies are needed, particularly in animal models, we believe that miR-146b can be currently considered as an oncomir in thyroid cancer. Our results contribute to this notion as we demonstrate that one of the strands specifically targets NIS and PAX8, key players in the dedifferentiation process occurring in thyroid cancer.
In contrast to expression profiling based on microarrays, next-generation sequencing enables the study of miRs at unprecedented quantitative and qualitative accuracy. As mentioned before, quantitative analysis helps to discriminate those miRs more functionally prominent. In fact, over 60% of detected miRs have no real activity, indicating that the functional miRNome of a cell is considerably smaller than previously thought (15) . Additionally, it allows the characterization of both the 3p and 5p mature strands of a given miR. The first study performing next-generation sequencing of miRs in PTC mainly focused on isomer analysis (39) . In another recent study, Huang et al.
analyzed the miRs expression datasets of PTC from The Cancer Genome Atlas (TCGA) Data Portal (38) . The authors emphasized that immune responses are significantly enriched and under specific regulation in the direct miR-target network, but miRs regulating thyroid differentiation genes were not addressed. Very recently, while preparing this manuscript, a study based on TCGA (16) showed that three selected miRs Statistical significance was evaluated by a two-tailed t test. Differences were considered significant at P < 0.05 (*); **, P < 0.01 to 0.001; ***, P < 0.001. G. Schematic representation of PAX8 and miR-146b regulating each other forming a feedback loop. represents the mean ± SE from three independent experiments performed in triplicate.
Statistical significance was evaluated by a two-tailed t test. Differences were considered significant at P < 0.05 (*); **, P < 0.01 to 0.001; ***, P < 0.001. common targets such as NIS. As a result, tumor cells adopt a less differentiated state that, for instance, makes them more insensitive to radioactive iodide. 
TABLES
